Tom Meade

11.9k total citations · 4 hit papers
23 papers, 3.9k citations indexed

About

Tom Meade is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Tom Meade has authored 23 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Pharmacology. Recurrent topics in Tom Meade's work include Inflammatory mediators and NSAID effects (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Cancer, Lipids, and Metabolism (4 papers). Tom Meade is often cited by papers focused on Inflammatory mediators and NSAID effects (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Cancer, Lipids, and Metabolism (4 papers). Tom Meade collaborates with scholars based in United Kingdom, United States and Japan. Tom Meade's co-authors include Peter M. Rothwell, J. J. F. Belch, Charles Warlow, Michelle Wilson, F.G.R. Fowkes, Hisao Ogawa, Jackie F. Price, Ziyah Mehta, Ale Algra and Carl‐Eric Elwin and has published in prestigious journals such as The Lancet, Spine and International Journal of Epidemiology.

In The Last Decade

Tom Meade

23 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

2010 1.1k citations Peter M. Rothwell, F.G.R. Fowkes et al. The Lancet profile →
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

2010 990 citations Peter M. Rothwell, Michelle Wilson et al. The Lancet profile →
Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials

2012 736 citations Peter M. Rothwell, Michelle Wilson et al. The Lancet profile →
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials

2012 628 citations Peter M. Rothwell, Jackie F. Price et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tom Meade United Kingdom	14	1.4k	1.2k	1.0k	679	659	23	3.9k
Michelle Wilson United Kingdom	5	942 0.7×	839 0.7×	695 0.7×	455 0.7×	449 0.7×	7	2.4k
Robert Fowler United States	7	1.7k 1.3×	477 0.4×	307 0.3×	345 0.5×	516 0.8×	10	2.7k
Chau T. Dang United States	39	351 0.3×	3.2k 2.6×	1.4k 1.4×	839 1.2×	979 1.5×	165	5.3k
Jeannette Bigler United States	42	680 0.5×	1.2k 1.0×	561 0.5×	1.8k 2.6×	108 0.2×	80	5.5k
Myrthe P. P. van Herk‐Sukel Netherlands	28	289 0.2×	873 0.7×	460 0.4×	598 0.9×	205 0.3×	69	2.3k
Balram Chowbay Singapore	37	417 0.3×	1.7k 1.4×	436 0.4×	1.4k 2.0×	195 0.3×	109	4.2k
Arthur L. Weaver United States	25	1.0k 0.7×	463 0.4×	182 0.2×	545 0.8×	354 0.5×	38	5.6k
Stuart Weiss United States	22	649 0.5×	2.0k 1.6×	333 0.3×	1.3k 1.9×	332 0.5×	28	5.8k
Hanna Mäenpää Finland	22	287 0.2×	365 0.3×	825 0.8×	945 1.4×	746 1.1×	54	4.8k
Guido Eibl United States	39	369 0.3×	2.0k 1.6×	839 0.8×	1.8k 2.6×	74 0.1×	102	4.1k

Countries citing papers authored by Tom Meade

Since Specialization

Citations

This map shows the geographic impact of Tom Meade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Meade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Meade more than expected).

Fields of papers citing papers by Tom Meade

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Meade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Meade. The network helps show where Tom Meade may publish in the future.

Co-authorship network of co-authors of Tom Meade

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Meade. A scholar is included among the top collaborators of Tom Meade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Meade. Tom Meade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Komnos, George Α., Tom Meade, Mohammad Mahdi Sarzaeem, et al.. (2024). Is There a Difference in the Outcome of Primary Total Knee Arthroplasty Performed Using Kinematic Versus Mechanical Alignment?. The Journal of Arthroplasty. 40(2). S88–S90. 1 indexed citations

Meade, Tom, Tim Clayton, & Douglas Chamberlain. (2016). Distinguishing between those dying suddenly or not suddenly from coronary heart disease: long-term prospective results from the Northwick Park Heart Study. Open Heart. 3(2). e000440–e000440. 1 indexed citations

Clayton, Tim, Tom Meade, Elizabeth L. Turner, & Bianca De Stavola. (2014). Peak flow rate and death due to coronary heart disease: 30-year results from the Northwick Park Heart cohort study. Open Heart. 1(1). e000164–e000164. 4 indexed citations

Rothwell, Peter M., Michelle Wilson, Jackie F. Price, et al.. (2012). Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. The Lancet. 379(9826). 1591–1601. 736 indexed citations breakdown →

Rothwell, Peter M., Jackie F. Price, F.G.R. Fowkes, et al.. (2012). Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. The Lancet. 379(9826). 1602–1612. 628 indexed citations breakdown →

Meade, Tom. (2012). Primary Prevention of Ischaemic Cardiovascular Disorders with Antiplatelet Agents. Handbook of experimental pharmacology. 565–605. 7 indexed citations

Rothwell, Peter M., F. Gerald R. Fowkes, J. J. F. Belch, et al.. (2011). Effect of Daily Aspirin on Long-Term Risk of Death Due to Cancer: Analysis of Individual Patient Data From Randomized Trials. Obstetrical & Gynecological Survey. 66(4). 222–223. 45 indexed citations

Rothwell, Peter M., F.G.R. Fowkes, J. J. F. Belch, et al.. (2010). Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. The Lancet. 377(9759). 31–41. 1090 indexed citations breakdown →

Rothwell, Peter M., Michelle Wilson, Carl‐Eric Elwin, et al.. (2010). Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. The Lancet. 376(9754). 1741–1750. 990 indexed citations breakdown →

10.

Pizzi, Costanza, Bianca De Stavola, & Tom Meade. (2009). Long-term association of routine blood count (Coulter) variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I). International Journal of Epidemiology. 39(1). 256–265. 17 indexed citations

11.

Vickers, Madge, Joseph Kim, Deborah Ford, et al.. (2009). Health-Related Quality of Life After Combined Hormone-Replacement Therapy: Randomized Controlled Trial: Women’s International Study of Long Duration Estrogen After the Menopause. Obstetrical & Gynecological Survey. 64(4). 238–240. 2 indexed citations

12.

Nacul, Luís, Michael Soljak, & Tom Meade. (2007). Model for estimating the population prevalence of chronic obstructive pulmonary disease: cross sectional data from the Health Survey for England. Population Health Metrics. 5(1). 8–8. 37 indexed citations

13.

Vickers, Madge, et al.. (2007). The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial. BMC Women s Health. 7(1). 2–2. 43 indexed citations

14.

Vickers, Madge, Alastair H. MacLennan, Beverley Lawton, et al.. (2007). Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women. BMJ. 335(7613). 239–239. 174 indexed citations

15.

MacCallum, Peter K., Alicja R. Rudnicka, Ann Rumley, Tom Meade, & Gordon Lowe. (2004). Low‐intensity warfarin reduces thrombin generation and fibrin turnover, but not low‐grade inflammation, in men at risk of myocardial infarction. British Journal of Haematology. 127(4). 448–450. 14 indexed citations

16.

Rudnicka, Alicja R., Deborah Ashby, Patrick J. Brennan, & Tom Meade. (2003). Thrombosis Prevention Trial. Archives of Internal Medicine. 163(12). 1454–1454. 13 indexed citations

17.

Radda, George K., et al.. (2002). The need for independent scientific peer review of Biobank UK. The Lancet. 359(9325). 2282–2282. 3 indexed citations

18.

Vickers, Madge, et al.. (1997). Community Studies of the Health Service Implications of Low Back Pain. Spine. 22(18). 2161–2166. 52 indexed citations

19.

Humphries, Steve E., Fiona R. Green, Anne Temple, et al.. (1992). Genetic factors determining thrombosis and fibrinolysis. Annals of Epidemiology. 2(4). 371–385. 16 indexed citations

20.

Baddeley, Alan, Tom Meade, & Freda Newcombe. (1980). Design problems in research on rehabilitation after brain damage. International Rehabilitation Medicine. 2(3). 138–142. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact